AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionOpinicus Capital, Inc.
Latest Disclosed Ownership10,709 shares
Latest Disclosed Value $ 2,328,971
Opinicus Capital, Inc. reports 1.56% increase in ownership of 4AB / AbbVie Inc.

On May 5, 2026 - Opinicus Capital, Inc. filed a 13F-HR form disclosing ownership of 10,709 shares of AbbVie Inc. (BG:4AB) valued at $2,328,971 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 10,544 shares of AbbVie Inc.. This represents a change in shares of 1.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ABBVIE COM 00287Y109 10,709 165 1.56 2,329 -3.36 1.6422
2026-02-04 2025-12-31 13F ABBVIE COM 00287Y109 10,544 -408 -3.73 2,409 -4.97 1.6797
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 10,952 714 6.97 2,536 33.42 1.7566
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 10,238 769 8.12 1,900 -4.19 1.4440
2025-04-16 2025-03-31 13F ABBVIE COM 00287Y109 9,469 252 2.73 1,984 21.14 1.7544
2025-01-28 2024-12-31 13F ABBVIE COM 00287Y109 9,217 458 5.23 1,638 -5.32 1.3771
2024-11-04 2024-09-30 13F ABBVIE COM 00287Y109 8,759 4 0.05 1,730 15.19 1.3826
2024-07-22 2024-06-30 13F ABBVIE COM 00287Y109 8,755 381 4.55 1,502 -1.51 1.2657
2024-04-16 2024-03-31 13F ABBVIE COM 00287Y109 8,374 11 0.13 1,525 17.59 1.3516
2024-02-05 2023-12-31 13F ABBVIE COM 00287Y109 8,363 8,363 1,296 1.3217
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.